Description
CJC-1295 (No DAC) supplied as a research reagent for in-vitro laboratory use. Every lot is assayed by reverse-phase HPLC to ≥98% purity, with identity confirmed by mass spectrometry and residual water content checked by Karl Fischer titration. Purity is verified across multiple independent laboratories, and material is sourced across multiple manufacturers so the highest-purity batch can be selected for release.
Specification
- CAS number: 863288-34-0
- Physical form: Lyophilised powder
- Purity: ≥98% by RP-HPLC
- Storage: 2°C – 8°C, protect from light
Research findings
- A GHRH(1–29) analogue binding the GHRH receptor on the anterior pituitary to stimulate GH release
- Albumin bioconjugates of hGRF(1–29) were identified as long-acting GRF analogues producing prolonged receptor activation in preclinical testing — the study that identified CJC-1295 [1]
- In healthy adults aged 21–61, a single subcutaneous dose of CJC-1295 with DAC produced dose-dependent increases in mean GH concentration and sustained IGF-1 elevation [2]
Regulatory status
RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION. Supplied strictly for in-vitro laboratory research by qualified professionals. Not a medicine, supplement, cosmetic or food. Must not be administered to humans or animals.
Vial and carton labels show 99% purity — the specification we aim for on every batch. Our guaranteed minimum is ≥98% by RP-HPLC, and the measured result for each batch appears on its certificate of analysis.
Reviews
There are no reviews yet.